Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center

About this trial

This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with a CNS tumors: this includes patients with primary brain tumors, brain metastases, and leptomeningeal disease

Established patients with a follow up encounter with Neuro-Oncology at the Brain and Spine Center at the University of Texas MD Anderson Cancer Center; this encounter can be

An in-person visit

A telemedicine appointment

Disqualifiers

Encounter occurred with the assistance of official language translation support

Patients with telephone encounters (without interactive video)

New patient or consult visits

Neither patient nor caregiver present during the visit are available or able to answer survey questions

Trial population

Patients with encounters at the Brain and Spine Center between 4/20/2020 and either (1) 8/30/2020 or (2) date that the state of emergency secondary to the COVID-19 pandemic is declared terminated in the United States of America- whichever date is earlier

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Electronic Health Record Review

    Other intervention

    Review of medical chart

  • Survey Administration

    Other intervention

    Complete survey

Treatment groups

200 Participants
are divided into 1 treatment group
Group A: Observational (survey, medical chart review)2 interventions

Trial outcomes

Primary outcomes

1

Survey response to question 6 of the quality of care survey ("I felt I received good medical care during this encounter")

Survey responses will be summarized by ordinal category as counts with percentages, separately by group. Will separately estimate the proportion of each ordinal level of each group with 95% confidence interval.

Time frame
through study completion, an average of 1 year

Secondary outcomes

1

Quality of Care Survey

Will separately estimate the proportion of each ordinal level of each group with 95% confidence interval.

Time frame
through study completion, an average of 1 year
2

Patients and clinical characteristics

Differences between groups will be assessed by 2-sample 2-sided t-test and Mann-Whitney test, Fisher's exact test, or chi-square test.

Time frame
Baseline
3

Interactive time spent during visit

Will be summarized by group per mean, median, standard deviation, and range. Differences between groups will be assessed by t-test and Mann-Whitney test.

Time frame
through study completion, an average of 1 year
4

Time from visit order placement to visit occurring

Will be summarized by group per mean, median, standard deviation, and range. Differences between groups will be assessed by t-test and Mann-Whitney test.

Time frame
through study completion, an average of 1 year

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.